<?xml version='1.0' encoding='UTF-8'?>
<Organism_Record>
  <Organism_ID>ASD09320000_1</Organism_ID>
  <Organism>Human</Organism>
  <Organism_Latin>Homo sapiens</Organism_Latin>
  <UniProt_ID>P11511</UniProt_ID>
  <Seq_Length>503</Seq_Length>
  <Molecule_Weight>57883</Molecule_Weight>
  <KEGG_ID>hsa:1588</KEGG_ID>
  <Orthology_ID>K07434</Orthology_ID>
  <Function_Summary>Catalyzes the formation of aromatic C18 estrogens from C19 androgens.</Function_Summary>
  <Catalytic_Mechanism>RH + reduced flavoprotein + O(2) = ROH + oxidized flavoprotein + H(2)O.</Catalytic_Mechanism>
  <Pfam_ID>PF00067:p450</Pfam_ID>
  <Allosteric_Activator_Count>2</Allosteric_Activator_Count>
  <Allosteric_Inhibitor_Count>14</Allosteric_Inhibitor_Count>
  <Allosteric_Regulator_Count>0</Allosteric_Regulator_Count>
  <Alias_List>
      <Alias>Aromatase</Alias>
      <Alias>CYPXIX</Alias>
      <Alias>Estrogen synthase</Alias>
      <Alias>Cytochrome P-450AROM</Alias>
  </Alias_List>
  <Function_List>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with heme, any compound of iron complexed in a porphyrin (tetrapyrrole) ring.</Detail>
      <Keyword>Heme binding</Keyword>
      <Ontology_ID>GO:0020037</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with iron (Fe) ions.</Detail>
      <Keyword>Iron ion binding</Keyword>
      <Ontology_ID>GO:0005506</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of the reduction of an aliphatic ring to yield an aromatic ring.</Detail>
      <Keyword>Aromatase activity</Keyword>
      <Ontology_ID>GO:0070330</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with oxygen (O2).</Detail>
      <Keyword>Oxygen binding</Keyword>
      <Ontology_ID>GO:0019825</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Any molecular entity that serves as an electron acceptor and electron donor in an electron transport system.</Detail>
      <Keyword>Electron carrier activity</Keyword>
      <Ontology_ID>GO:0009055</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of the incorporation of one atom from molecular oxygen into a compound and the reduction of the other atom of oxygen to water.</Detail>
      <Keyword>Monooxygenase activity</Keyword>
      <Ontology_ID>GO:0004497</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with any metal ion.</Detail>
      <Keyword>Metal ion binding</Keyword>
      <Ontology_ID>GO:0046872</Ontology_ID>
    </Funtion>
  </Function_List>
  <Mutation_List>
    <Muntion>
      <Position>435</Position>
      <Original>Arg</Original>
      <Variation>Cys</Variation>
    </Muntion>
    <Muntion>
      <Position>375</Position>
      <Original>Arg</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>375</Position>
      <Original>Arg</Original>
      <Variation>Cys</Variation>
    </Muntion>
    <Muntion>
      <Position>264</Position>
      <Original>Arg</Original>
      <Variation>Cys</Variation>
    </Muntion>
    <Muntion>
      <Position>437</Position>
      <Original>Cys</Original>
      <Variation>Tyr</Variation>
    </Muntion>
    <Muntion>
      <Position>39</Position>
      <Original>Trp</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>365</Position>
      <Original>Arg</Original>
      <Variation>Gln</Variation>
    </Muntion>
    <Muntion>
      <Position>201</Position>
      <Original>Thr</Original>
      <Variation>Met</Variation>
    </Muntion>
  </Mutation_List>
  <BioProcess_List>
    <BioProcess>
      <Detail>The increase in size or mass of the prostate gland where the increase in size or mass has the specific outcome of the progression of the gland, from its formation to its mature state.</Detail>
      <Keyword>Prostate gland growth</Keyword>
      <Ontology_ID>GO:0060736</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The chemical reactions and pathways resulting in the formation of estrogens, C18 steroid hormones that can stimulate the development of female sexual characteristics. Also found in plants.</Detail>
      <Keyword>Estrogen biosynthetic process</Keyword>
      <Ontology_ID>GO:0006703</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The chemical reactions and pathways involving a xenobiotic compound, a compound foreign to living organisms. Used of chemical compounds, e.g. a xenobiotic chemical, such as a pesticide.</Detail>
      <Keyword>Xenobiotic metabolic process</Keyword>
      <Ontology_ID>GO:0006805</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The chemical reactions and pathways involving androgens, C19 steroid hormones that can stimulate the development of male sexual characteristics.</Detail>
      <Keyword>Androgen metabolic process</Keyword>
      <Ontology_ID>GO:0008209</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The chemical reactions and pathways involving small molecules, any monomeric molecule of small relative molecular mass.</Detail>
      <Keyword>Small molecule metabolic process</Keyword>
      <Ontology_ID>GO:0044281</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A metabolic process that results in the removal or addition of one or more electrons to or from a substance, with or without the concomitant removal or addition of a proton or protons.</Detail>
      <Keyword>Oxidation-reduction process</Keyword>
      <Ontology_ID>GO:0055114</Ontology_ID>
    </BioProcess>
  </BioProcess_List>
  <Molecule_Seq>
    <Protein_Seq>MVLEMLNPIHYNITSIVPEAMPAATMPVLLLTGLFLLVWNYEGTSSIPGPGYCMGIGPLISHGRFLWMGIGSACNYYNRVYGEFMRVWISGEETLIISKSSSMFHIMKHNHYSSRFGSKLGLQCIGMHEKGIIFNNNPELWKTTRPFFMKALSGPGLVRMVTVCAESLKTHLDRLEEVTNESGYVDVLTLLRRVMLDTSNTLFLRIPLDESAIVVKIQGYFDAWQALLIKPDIFFKISWLYKKYEKSVKDLKDAIEVLIAEKRRRISTEEKLEECMDFATELILAEKRGDLTRENVNQCILEMLIAAPDTMSVSLFFMLFLIAKHPNVEEAIIKEIQTVIGERDIKIDDIQKLKVMENFIYESMRYQPVVDLVMRKALEDDVIDGYPVKKGTNIILNIGRMHRLEFFPKPNEFTLENFAKNVPYRYFQPFGFGPRGCAGKYIAMVMMKAILVTLLRRFHVKTLQGQCVESIQKIHDLSLHPDETKNMLEMIFTPRNSDRCLEH</Protein_Seq>
    <DNA_Seq>GGGAGTTTCTGGAGGGCTGAACACGTGGAGGCAAACAGGAAGGTGAAGAAGAACTTATCCTATCAGGACGGAAGGTCCTGTGCTCGGGATCTTCCAGACGTCGCGACTCTAAATTGCCCCCTCTGAGGTCAAGGAACACAAGATGGTTTTGGAAATGCTGAACCCGATACATTATAACATCACCAGCATCGTGCCTGAAGCCATGCCTGCTGCCACCATGCCAGTCCTGCTCCTCACTGGCCTTTTTCTCTTGGTGTGGAATTATGAGGGCACATCCTCAATACCAGGTCCTGGCTACTGCATGGGAATTGGACCCCTCATCTCCCACGGCAGATTCCTGTGGATGGGGATCGGCAGTGCCTGCAACTACTACAACCGGGTATATGGAGAATTCATGCGAGTCTGGATCTCTGGAGAGGAAACACTCATTATCAGCAAGTCCTCAAGTATGTTCCACATAATGAAGCACAATCATTACAGCTCTCGATTCGGCAGCAAACTTGGGCTGCAGTGCATCGGTATGCATGAGAAAGGCATCATATTTAACAACAATCCAGAGCTCTGGAAAACAACTCGACCCTTCTTTATGAAAGCTCTGTCAGGCCCCGGCCTTGTTCGTATGGTCACAGTCTGTGCTGAATCCCTCAAAACACATCTGGACAGGTTGGAGGAGGTGACCAATGAATCGGGCTATGTGGACGTGTTGACCCTTCTGCGTCGTGTCATGCTGGACACCTCTAACACGCTCTTCTTGAGGATCCCTTTGGACGAAAGTGCTATCGTGGTTAAAATCCAAGGTTATTTTGATGCATGGCAAGCTCTCCTCATCAAACCAGACATCTTCTTTAAGATTTCTTGGCTATACAAAAAGTATGAGAAGTCTGTCAAGGATTTGAAAGATGCCATAGAAGTTCTGATAGCAGAAAAAAGACGCAGGATTTCCACAGAAGAGAAACTGGAAGAATGTATGGACTTTGCCACTGAGTTGATTTTAGCAGAGAAACGTGGTGACCTGACAAGAGAGAATGTGAACCAGTGCATATTGGAAATGCTGATCGCAGCTCCTGACACCATGTCTGTCTCTTTGTTCTTCATGCTATTTCTCATTGCAAAGCACCCTAATGTTGAAGAGGCAATAATAAAGGAAATCCAGACTGTTATTGGTGAGAGAGACATAAAGATTGATGATATACAAAAATTAAAAGTGATGGAAAACTTCATTTATGAGAGCATGCGGTACCAGCCTGTCGTGGACTTGGTCATGCGCAAAGCCTTAGAAGATGATGTAATCGATGGCTACCCAGTGAAAAAGGGGACAAACATTATCCTGAATATTGGAAGGATGCACAGACTCGAGTTTTTCCCCAAACCCAATGAATTTACTCTTGAAAATTTTGCAAAGAATGTTCCTTATAGGTACTTTCAGCCATTTGGCTTTGGGCCCCGTGGCTGTGCAGGAAAGTACATCGCCATGGTGATGATGAAAGCCATCCTCGTTACACTTCTGAGACGATTCCACGTGAAGACATTGCAAGGACAGTGTGTTGAGAGCATACAGAAGATACACGACTTGTCCTTGCACCCAGATGAGACTAAAAACATGCTGGAAATGATCTTTACCCCAAGAAACTCAGACAGGTGTCTGGAACACTAGAGAAGGCTGGTCAGTACCCACTCTGGAGCATTTCTCATCAGTAGTTCACATACAAATCATCCATCCTTGCCAATAGTGTCATCCTCACAGTGAACACTCAGTGGCCCATGGCATTTTATAGGCATACCTCCTATGGGTTGTCACCAAGCTAGGTGCTATTTGTCATCTGCTCCTGTTCACACCAGAGAACCAGGCTACAAGAGAAAAAGCAGAGGCCAAGAGTTTGAGGGAGAAATAGTCGGTGAAGAAACCGTATCCATAAAGACCCGATTCCACCAAATGTGCTTTGAGAAGGATAGGCCTTCATTAACAAAATGTATGTCTGGTTCCCCAGTAGAGCTCTACTGCCTCAACCCAAGGGGATTTTTATGTCTGGGGCAGAAACACTCAAGTTGATTAGAAAGACCAGGCCAATGTCAGGGTACCTGGGGCCAAACCCACCTGCTAGTGTGAATTAAAGTACTTTAATTTTGTTTTCTGTGGAGGTGGAAAAGCAACATTCATAGTCTTTGGAGAAATGCTTAGAAATTCAGCATTTGACCCTTGCTGTGAATTAAGCCCAATTAATTCCTGTTTGTCTACATATGATCTGTCTGTGGCAAAAGTTTAATCAGAGGAAATTCTTTCCCAGTCTGTCGATTTATGCCTCAGCCACTTGCCTGTGCTACAATTCATTGTGTTACCTGTAGATTCAGGTAATACAAACTATATATAATCATCAAGTAATACAAACTAATTTAGTAATAGCCTGGGTTAAGTATTATTAGGGCCCTGTGTCTGCTGTAGAAAAAAAAATTCACATGATGCACTTCAAATTCAAATAAAAATCCTTTTGGCATGTTCCCATTTTTGCTTAGCTCAATTAGTGTGGCTAACCAAGAGATAACTGTAAATGTGACATTGATTTGCTCTTACTACAGCTTCAGTGATTGGGGGAGGAAAAGTCCCAACCCAATGGGCTCAAACTTCTAAGGGGTACTCCTCTCATCCCCTTATCCTTCTCCCTCGACATTTTCTCCCTCTTTCTTCCCATGACCCCAAAGCCAAGGGCAACAGATCAGTAAAGAACGTGGTCAGAGTAGAACCCCTGAAGTATTTTTTAATCCTACCTCAAAATTTAACAGTTACCTGAGAGATTTAACATTATCTAGTTCATTGAATCATTGTATGTGGTCATGGATAAATTGCACACCTTGGAATTCGCTTTCTAAAGGAAATCAAATGAATGGAGGAACTTTCCAAACACCACTTTACTTGTGTTATATAGCCAATATAACTATCTCTACTGAATGTCATTGAAAAACTAAAAAATTAAACTTATTTACAAATAGGTAAATATTTGTCATTGAATCCATTGCCATCCCATTTGACTGTTCTTTTCATCCTACTGTCTAGTAATAAGCTGAGTATAAGATGACAGTGTAATCTCCCTGAAAGCAGGAGCTACTTTCTTTCTTTTGTAATCTATTTCCATCCCCATTTCCCTGTCCTGTCTCCCTGTATTCACTCCCAAGCTCAGTTCTGAATAGACATTCCTGCTCAGAGATACTCCCAACTGATGCAGAAACCAAATAAAGAGGTAGGTATTCCAAGAATTCAAGAATGGACATTAGTAAAGAATAAAACATTTATTTGAGCTTGGAATTATTTGGATCATCTATATGGCCTAAAAATATATGGACTATGCCTGTGTACCTGAATACGTATGTAGTCAGGTCAAGACAATCATCCAAATAACTTAGACCCCTAAAAGCAAGGCCAGGATTTGCAATTTAATGTGTCCCAATTAATTCACTTGAAAATTAGTAACACTCTGTTTACGTTGCCTCTGGCTGGAGCTGCATGGTGGAAGAAGCCCAACTTTGGATCCATGTACTTCACCCATCCAATACTCTTGGGACATTTATGTGTATTTTATCTGTATATATGAAGCCAATGTCTATGTCTACACAGTCAAAGTGAAATGCATGTTTGATATAGCTGTACATAGATATCTATTTTGCAGGTACAAAAATATCCTGGGGGAAAACTGGGAGTGGAAGGGTGGGGGGTGGGAGTGAGGGACATGGGGGAGGGACAGGAAGAGGAGAAGTGTTGGTTTGAACGATCCAAGCAAACTCTCCCAGAATCAAATTACCTGGGTAGTTGTTCAACTTTTCACTCTGCTTAGCCTGTATAGACAAACCCCATATATTTGTAGAGGCTTGGCCTTGGAATTCTGGAATACCATTGGCTTTTCAGTAGGCTGATGAACACATTTTGAAAATTCTATTATCTTCAGAATTTTGCCCCATTGTTAAGTGCTTAACCGTCACTCTTGAATGTGCAATGTGCTGTGGATTCCATTTTCATCAGTTCTGAAAGAACTGCAATGTGTAAATTATCAGTGAAATGCATGCATATAAGGGCTCTATCATTATCAAATTGTAAGGACAATTGTACCCTTCTATATCTTTGGGCATGCTAGACACCCCCATGCCTTCATTGAGATCCCATTTTCCCCCTCTCAAGTGGAAAATAATCACATCCAGCAAGCTCTCTCATTATTGAGAAATACCATTTGGAAATTGCCACTTTTTATTCCTAAGCAGCACCTTTCACTGTTCATGATGCTAATGTTCCACAAAAGCATGTGCCATTGGCCCACTGAAGGATAGAGGGACCCTTTTCAATCTATATCAGCTGGGCTCTGGGACTGAATCTCTCACCTATTCTTGCAGAAAGACATACTAATTAAACCTTGTCAAAGTAAAAAAAAAAAAAAAAAA</DNA_Seq>
  </Molecule_Seq>
  <Tissuelocal_List>
    <TissueLocal>
      <TissueLocal>Placenta</TissueLocal>
    </TissueLocal>
    <TissueLocal>
      <TissueLocal>Brain</TissueLocal>
    </TissueLocal>
    <TissueLocal>
      <TissueLocal>Gonad</TissueLocal>
    </TissueLocal>
  </Tissuelocal_List>
  <CellLocal_List>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Membrane</CellLocal>
      <Ontology_ID>GO:0016020</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Endoplasmic reticulum membrane</CellLocal>
      <Ontology_ID>GO:0005789</Ontology_ID>
    </AsdMacromoleculeCelllocal>
  </CellLocal_List>
  <Gene>
    <Gene_Name>CYP19A1</Gene_Name>
    <Gene_Alias>ARO1; CYAR; CYP19</Gene_Alias>
    <Gene_ID>1588</Gene_ID>
    <Genbank_ACCN>NM_000103</Genbank_ACCN>
    <Protein_ACCN>NP_000094</Protein_ACCN>
    <HGNC_ID>2594</HGNC_ID>
    <Gene_URL>http://www.ncbi.nlm.nih.gov/gene/1588</Gene_URL>
    <UCSC_ID>uc001zyz.4</UCSC_ID>
    <EMBL_ID>ENSG00000137869</EMBL_ID>
  </Gene>
  <Disease_List>
    <Disease>
      <Disease_Name>Breast Cancer</Disease_Name>
      <Disease_Detail>Breast Cancer</Disease_Detail>
      <Disease_DB>BRS047</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/breast_cancer?search=CYP19A1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Choriocarcinoma</Disease_Name>
      <Disease_Detail>Choriocarcinoma</Disease_Detail>
      <Disease_DB>CHR074</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/choriocarcinoma?search=CYP19A1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Osteoporosis</Disease_Name>
      <Disease_Detail>Osteoporosis</Disease_Detail>
      <Disease_DB>OST002</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/osteoporosis?search=CYP19A1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Gender Identity Disorder</Disease_Name>
      <Disease_Detail>Gender Identity Disorder</Disease_Detail>
      <Disease_DB>GND002</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/gender_identity_disorder?search=CYP19A1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Breast Fibroadenoma</Disease_Name>
      <Disease_Detail>Breast Cancer</Disease_Detail>
      <Disease_DB>BRS053</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/breast_fibroadenoma?search=CYP19A1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Antley-Bixler Syndrome</Disease_Name>
      <Disease_Detail>Antley-Bixler Syndrome</Disease_Detail>
      <Disease_DB>ANT003</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/antley_bixler_syndrome?search=CYP19A1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Male Breast Cancer</Disease_Name>
      <Disease_Detail>Breast Cancer</Disease_Detail>
      <Disease_DB>MLB002</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/male_breast_cancer?search=CYP19A1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Aromatase Excess Syndrome</Disease_Name>
      <Disease_Detail>Aromatase Excess Syndrome</Disease_Detail>
      <Disease_DB>ARM004</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/aromatase_excess_syndrome?search=CYP19A1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Gynecomastia</Disease_Name>
      <Disease_Detail>Gynecomastia</Disease_Detail>
      <Disease_DB>GYN001</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/gynecomastia?search=CYP19A1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Ovarian Serous Cystadenocarcinoma</Disease_Name>
      <Disease_Detail>Ovarian Cancer</Disease_Detail>
      <Disease_DB>OVR012</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/ovarian_serous_cystadenocarcinoma?search=CYP19A1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Premature Ejaculation</Disease_Name>
      <Disease_Detail>Premature Ejaculation</Disease_Detail>
      <Disease_DB>PRM003</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/premature_ejaculation?search=CYP19A1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Testotoxicosis</Disease_Name>
      <Disease_Detail>Testotoxicosis</Disease_Detail>
      <Disease_DB>TST023</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/testotoxicosis?search=CYP19A1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Transsexualism</Disease_Name>
      <Disease_Detail>Transsexualism</Disease_Detail>
      <Disease_DB>TRN007</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/transsexualism?search=CYP19A1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Complete Androgen Insensitivity Syndrome</Disease_Name>
      <Disease_Detail>Complete Androgen Insensitivity Syndrome</Disease_Detail>
      <Disease_DB>CMP034</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/complete_androgen_insensitivity_syndrome?search=CYP19A1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Androgen Insensitivity Syndrome</Disease_Name>
      <Disease_Detail>Androgen Insensitivity Syndrome</Disease_Detail>
      <Disease_DB>AND002</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/androgen_insensitivity_syndrome?search=CYP19A1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Benign Metastasizing Leiomyoma</Disease_Name>
      <Disease_Detail>Benign Metastasizing Leiomyoma</Disease_Detail>
      <Disease_DB>BNG041</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/benign_metastasizing_leiomyoma?search=CYP19A1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Endometriosis</Disease_Name>
      <Disease_Detail>Endometriosis</Disease_Detail>
      <Disease_DB>END044</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/endometriosis?search=CYP19A1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Mycetoma</Disease_Name>
      <Disease_Detail>Mycetoma</Disease_Detail>
      <Disease_DB>MYC012</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/mycetoma?search=CYP19A1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Serous Cystadenocarcinoma</Disease_Name>
      <Disease_Detail>Serous Cystadenocarcinoma</Disease_Detail>
      <Disease_DB>SRS001</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/serous_cystadenocarcinoma?search=CYP19A1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Testicular Leydig Cell Tumor</Disease_Name>
      <Disease_Detail>Testicular Leydig Cell Tumor</Disease_Detail>
      <Disease_DB>TST001</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/testicular_leydig_cell_tumor?search=CYP19A1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Leydig Cell Tumor</Disease_Name>
      <Disease_Detail>Leydig Cell Tumor</Disease_Detail>
      <Disease_DB>LYD001</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/leydig_cell_tumor?search=CYP19A1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Precocious Puberty, Male</Disease_Name>
      <Disease_Detail>Precocious Puberty</Disease_Detail>
      <Disease_DB>PRC030</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/precocious_puberty_male?search=CYP19A1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Leiomyoma</Disease_Name>
      <Disease_Detail>Leiomyoma</Disease_Detail>
      <Disease_DB>LMY002</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/leiomyoma?search=CYP19A1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Hypoactive Sexual Desire Disorder</Disease_Name>
      <Disease_Detail>Hypoactive Sexual Desire Disorder</Disease_Detail>
      <Disease_DB>HYP030</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/hypoactive_sexual_desire_disorder?search=CYP19A1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Estrogen Excess</Disease_Name>
      <Disease_Detail>Estrogen Excess</Disease_Detail>
      <Disease_DB>EST004</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/estrogen_excess?search=CYP19A1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Uterine Disease</Disease_Name>
      <Disease_Detail>Uterine Disease</Disease_Detail>
      <Disease_DB>UTR038</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/uterine_disease?search=CYP19A1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Primary Pigmented Nodular Adrenocortical Disease</Disease_Name>
      <Disease_Detail>Primary Pigmented Nodular Adrenocortical Disease</Disease_Detail>
      <Disease_DB>PRM051</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/primary_pigmented_nodular_adrenocortical_disease?search=CYP19A1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Osteonecrosis of the Jaw</Disease_Name>
      <Disease_Detail>Osteonecrosis of the Jaw</Disease_Detail>
      <Disease_DB>OST115</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/osteonecrosis_of_the_jaw?search=CYP19A1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Ovarian Disease</Disease_Name>
      <Disease_Detail>Ovarian Disease</Disease_Detail>
      <Disease_DB>OVR049</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/ovarian_disease?search=CYP19A1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Aromatase Deficiency</Disease_Name>
      <Disease_Detail>Aromatase Deficiency</Disease_Detail>
      <Disease_DB>ARM001</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/aromatase_deficiency?search=CYP19A1#related_genes</Disease_URL>
    </Disease>
  </Disease_List>
  <PDB_List>
    <PDB>
      <PDB_Title>Crystal structure of human placental aromatase cytochrome P450 in complex with androstenedione</PDB_Title>
      <PDB_ID>3EQM</PDB_ID>
      <Resolution>2.9</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3EQM</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structural basis for androgen specificity and oestrogen synthesis in human aromatase.</PubMed_Title>
      <Author>Ghosh, D., et al.</Author>
      <Journal>Nature(2009)457:219-223</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/19129847?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Structure of human placental aromatase complexed with designed inhibitor HDDG029 (compound 4)</PDB_Title>
      <PDB_ID>4GL5</PDB_ID>
      <Resolution>3.48</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=4GL5</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Novel aromatase inhibitors by structure-guided design.</PubMed_Title>
      <Author>Ghosh, D., et al.</Author>
      <Journal>J.Med.Chem.(2012)55:8464-8476</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/22951074?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of human placental aromatase complexed with breast cancer drug exemestane</PDB_Title>
      <PDB_ID>3S7S</PDB_ID>
      <Resolution>3.21</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3S7S</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Novel aromatase inhibitors by structure-guided design.</PubMed_Title>
      <Author>Ghosh, D., et al.</Author>
      <Journal>J.Med.Chem.(2012)55:8464-8476</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/22951074?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Human placental aromatase cytochrome P450 (CYP19A1) refined at 2.75 angstrom</PDB_Title>
      <PDB_ID>3S79</PDB_ID>
      <Resolution>2.75</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3S79</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Novel aromatase inhibitors by structure-guided design.</PubMed_Title>
      <Author>Ghosh, D., et al.</Author>
      <Journal>J.Med.Chem.(2012)55:8464-8476</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/22951074?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Structure of human placental aromatase complexed with designed inhibitor HDDG046 (compound 5)</PDB_Title>
      <PDB_ID>4GL7</PDB_ID>
      <Resolution>3.9</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=4GL7</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Novel aromatase inhibitors by structure-guided design.</PubMed_Title>
      <Author>Ghosh, D., et al.</Author>
      <Journal>J.Med.Chem.(2012)55:8464-8476</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/22951074?dopt=Abstract</PubMed_ID>
    </PDB>
  </PDB_List>
  <Network_List>
    <Network>
      <Pathway_ID>ko04913</Pathway_ID>
      <Pathway_Title>Ovarian steroidogenesis</Pathway_Title>
      <Pathway_Class>Organismal Systems</Pathway_Class>
      <Pathway_Subclass>Endocrine system</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko00140</Pathway_ID>
      <Pathway_Title>Steroid hormone biosynthesis</Pathway_Title>
      <Pathway_Class>Metabolism</Pathway_Class>
      <Pathway_Subclass>Lipid metabolism</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko00140</Pathway_ID>
      <Pathway_Title>Steroid hormone biosynthesis</Pathway_Title>
      <Pathway_Class>Metabolism</Pathway_Class>
      <Pathway_Subclass>Lipid metabolism</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko00140</Pathway_ID>
      <Pathway_Title>Steroid hormone biosynthesis</Pathway_Title>
      <Pathway_Class>Metabolism</Pathway_Class>
      <Pathway_Subclass>Lipid metabolism</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko00140</Pathway_ID>
      <Pathway_Title>Steroid hormone biosynthesis</Pathway_Title>
      <Pathway_Class>Metabolism</Pathway_Class>
      <Pathway_Subclass>Lipid metabolism</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko00140</Pathway_ID>
      <Pathway_Title>Steroid hormone biosynthesis</Pathway_Title>
      <Pathway_Class>Metabolism</Pathway_Class>
      <Pathway_Subclass>Lipid metabolism</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko00140</Pathway_ID>
      <Pathway_Title>Steroid hormone biosynthesis</Pathway_Title>
      <Pathway_Class>Metabolism</Pathway_Class>
      <Pathway_Subclass>Lipid metabolism</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04913</Pathway_ID>
      <Pathway_Title>Ovarian steroidogenesis</Pathway_Title>
      <Pathway_Class>Organismal Systems</Pathway_Class>
      <Pathway_Subclass>Endocrine system</Pathway_Subclass>
    </Network>
  </Network_List>
  <AllostericSite_List>
    <AllostericSite>
      <Site_Detail>site,374,Met;site,370,Val;site,477,Leu</Site_Detail>
      <Site_Reference>Lu D, et al. Eur J Pharmacol. 2012 Sep 15;691(1-3):275-82.</Site_Reference>
      <PDB_ID>3S7S;4GL5;4GL7</PDB_ID>
      <PubMed_ID>22796452</PubMed_ID>
    </AllostericSite>
  </AllostericSite_List>
  <Enzyme_Nomenclature_List>
    <Enzyme_Nomenclature>
      <Enzyme_DB_ID>1.14.14.1</Enzyme_DB_ID>
      <Enzyme_DB_URL>http://www.chem.qmul.ac.uk/iubmb/enzyme/EC1/14/14/1.html</Enzyme_DB_URL>
    </Enzyme_Nomenclature>
  </Enzyme_Nomenclature_List>
  <Modulator_List>
    <Modulator>
      <ASD_ID>ASD09320001</ASD_ID>
      <Modulator_Feature>Activator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD09320002</ASD_ID>
      <Modulator_Feature>Activator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD09320003</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD09320004</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD09320005</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD09320006</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD09320007</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD09320008</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD09320009</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD09320010</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD09320011</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD09320012</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD09320013</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD09320014</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD09320015</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD09320016</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
  </Modulator_List>
  <Create_Date>2013-04-23</Create_Date>
</Organism_Record>